Minimizing fucosylation in insect cell-derived glycoproteins reduces binding to IgE antibodies from the sera of patients with allergy

Tnao38, high five and Sf9—evaluation of host–virus interactions in three different insect cell lines: baculovirus production and recombinant protein expression

(2013) Monika Wilde et al.   BIOTECHNOLOGY LETTERS

A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells

(2013) H. Mabashi-Asazuma et al.   GLYCOBIOLOGY

SweetBac: A New Approach for the Production of Mammalianised Glycoproteins in Insect Cells

(2012) Dieter Palmberger et al.   PLoS One

A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates

(2012) Florian Krammer et al.   PLoS One

MultiBac turns sweet

(2012) Dieter Palmberger et al.   Bioengineered

A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway

(2011) Jared J Aumiller et al.   GLYCOBIOLOGY

Insect cells for antibody production: Evaluation of an efficient alternative

(2011) Dieter Palmberger et al.   JOURNAL OF BIOTECHNOLOGY

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

(2011) Constantino López-Macías et al.   VACCINE

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial

(2011) John J. Treanor et al.   VACCINE

Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase

(2010) H. H. von Horsten et al.   GLYCOBIOLOGY

New baculovirus expression tools for recombinant protein complex production

(2010) Simon Trowitzsch et al.   JOURNAL OF STRUCTURAL BIOLOGY

Trichoplusia ni cells (High FiveTM) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

(2010) Florian Krammer et al.   MOLECULAR BIOTECHNOLOGY

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood

(2009) Shigeru Iida et al.   BMC CANCER

Allergenicity of Carbohydrates and Their Role in Anaphylactic Events

(2009) Scott P. Commins et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: The N-glycan structures are needed for the human antibody recognition

(2009) Ulla Seppälä et al.   MOLECULAR IMMUNOLOGY

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

(2008) John T. Schiller et al.   VACCINE